Avalo Therapeutics Inc (NAS:AVTX)
$ 9.55 -0.44 (-4.4%) Market Cap: 99.93 Mil Enterprise Value: 18.62 Mil PE Ratio: 0 PB Ratio: 4.39 GF Score: 47/100

Avalo Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 14, 2022 / 01:30PM GMT
Release Date Price: $1270.08 (+0.23%)
Garry Neil
Avalo Therapeutics, Inc. - Chairman & CEO

Good morning. I'm Garry Neil, Chief Executive Officer of Avalo Therapeutics. I've been asked by Steven Boyd, Chairman of the Board of Directors of the company, to preside at this annual meeting.

I would like to officially call the meeting to order, and welcome you all to the 2022 Annual Shareholders Meeting of Avalo Therapeutics, Inc. This meeting is being held virtually in an effort to make the meeting as accessible as possible to our stockholders. We appreciate your participation today, and we look forward to future stockholders' meetings where we can all be together in person.

Before proceeding to the business of the meeting, I'd like to introduce you to the members of our Board of Directors who are in attendance today through remote access: Steven Boyd, Board Chairman; June Almenoff; Mitchell Chan; Gilla Kaplan; Keith Maher; and Magnus Persson. In addition to members of our Board, we also have the following representatives of management present today through remote access: Chris Sullivan, Chief Financial Officer. Mr. Sullivan

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot